Andy Cohen has revealed he took a small dose of a "revolutionary" GLP-1 weight loss drug over the summer and lost 25 pounds.

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Dr. Buettner points out that glucagon, which is targeted by the new medication, can raise a person’s heart rate and may ...

There’s virtually no published scientific evidence that shows microdosing drugs like tirzepatide (the active ingredient in ...

As people come off GLP-1 medications like Ozempic and Wegovy, Virtua Health and other companies are pushing behavior-based ...

Weight-loss drugs such as Wegovy, Zepbound, and other GLP-1 medications are no longer covered for TRICARE For Life (TFL) ...

Cigna said on Wednesday the percentage of employers paying for obesity drugs has remained flat year-over-year, though the ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

The Bravo TV kingpin has opened up on his experience with the wildly popular Ozempic-like drugs that many have turned to for ...

Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had been approved by the US Food ...

In a revealing preclinical study, the weight-loss drug tirzepatide—already known for fighting obesity and diabetes—unexpectedly slowed the growth of breast cancer tumors in obese mice. Researchers ...